Loading…

Impact of CD33 and ABCB1 single nucleotide polymorphisms in patients with acute myeloid leukemia and advanced myeloid malignancies treated with decitabine plus gemtuzumab ozogamicin

Saved in:

Bibliographic Details
Published in:	American journal of hematology 2020-09, Vol.95 (9), p.E225-E228
Main Authors:	Short, Nicholas J., Richard‐Carpentier, Guillaume, Kanagal‐Shamanna, Rashmi, Patel, Keyur P., Konopleva, Marina, Papageorgiou, Ioannis, Pemmaraju, Naveen, Borthakur, Gautam, Ravandi, Farhad, DiNardo, Courtney D., Kadia, Tapan M., Kantarjian, Hagop, Lamba, Jatinder K., Daver, Naval
Format:	Article
Language:	English
Subjects:	5-aza-2'-deoxycytidine Acute myeloid leukemia Adult Antineoplastic Combined Chemotherapy Protocols - administration & dosage ATP Binding Cassette Transporter, Subfamily B - genetics Decitabine - administration & dosage Female Gemtuzumab - administration & dosage Gemtuzumab ozogamicin Hematologic Neoplasms - drug therapy Hematologic Neoplasms - genetics Hematologic Neoplasms - mortality Hematology Humans Immunotherapy Leukemia, Myeloid, Acute - drug therapy Leukemia, Myeloid, Acute - genetics Leukemia, Myeloid, Acute - mortality Male Monoclonal antibodies Myeloid leukemia Neoplasm Proteins - genetics Polymorphism, Single Nucleotide Sialic Acid Binding Ig-like Lectin 3 - genetics Single-nucleotide polymorphism Targeted cancer therapy
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!